Back
Mersana Therapeutics Stock Price Chart
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
MRSN
Mersana Therapeutics
Last Price:
2.13
Seasonality Move:
41.89%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRSN is experiencing slight buying pressure.
Mersana Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.93 | Buy |
| 20-day SMA: | 1.92 | Buy |
| 50-day SMA: | 1.69 | Buy |
| 200-day SMA: | 2.81 | Sell |
| 8-day EMA: | 1.98 | Buy |
| 20-day EMA: | 1.89 | Buy |
| 50-day EMA: | 1.85 | Buy |
| 200-day EMA: | 2.47 | Sell |
Mersana Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 61.73 | Buy |
| Chaikin Money Flow: | 769876 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.58 - 2.08) | Buy |
| Bollinger Bands (100): | (1.59 - 2.31) | Buy |
Mersana Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mersana Therapeutics Stock
Is Mersana Therapeutics Stock a Buy?
- Mersana Therapeutics share price is 2.12 while MRSN 8-day simple moving average is 1.93, which is a Buy signal.
- The stock price of MRSN is 2.12 while Mersana Therapeutics 20-day SMA is 1.92, which makes it a Buy.
- Mersana Therapeutics 50-day simple moving average is 1.69 while MRSN share price is 2.12, making it a Buy technically.
- MRSN stock price is 2.12 and Mersana Therapeutics 200-day simple moving average is 2.81, creating a Sell signal.
MRSN Technical Analysis vs Fundamental Analysis
Sell
46
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy or a Sell?
-
Mersana Therapeutics stock is rated a Sell
The current Mersana Therapeutics [MRSN] share price is $2.12. The Score for MRSN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Mersana Therapeutics Stock Info
Market Cap:
260.07M
Price in USD:
2.12
Share Volume:
1.98M
Mersana Therapeutics 52-Week Range
52-Week High:
6.28
52-Week Low:
1.07
Sell
46
Mersana Therapeutics (MRSN)
is a Sell
Mersana Therapeutics Share Price Forecast
-
What is the Mersana Therapeutics stock price today?
The Mersana Therapeutics stock price is 2.12 USD today. -
Will MRSN stock go up or go down?
Mersana Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Mersana Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mersana Therapeutics is overvalued.
Is Mersana Therapeutics Stock a Buy?
- Mersana Therapeutics share price is 2.12 while MRSN 8-day exponential moving average is 1.98, which is a Buy signal.
- The stock price of MRSN is 2.12 while Mersana Therapeutics 20-day EMA is 1.89, which makes it a Buy.
- Mersana Therapeutics 50-day exponential moving average is 1.85 while MRSN share price is 2.12, making it a Buy technically.
- MRSN stock price is 2.12 and Mersana Therapeutics 200-day simple moving average is 2.47, creating a Sell signal.
Fundamental Analysis of Mersana Therapeutics
Is Mersana Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Mersana Therapeutics
Should I short Mersana Therapeutics stock?
- MRSN Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Mersana Therapeutics is a Buy
- Mersana Therapeutics Relative Strength Index (RSI) is 61.73, which suggest Mersana Therapeutics is overbought
- The Bollinger Bands (25) for Mersana Therapeutics is (1.58 - 2.08), which suggest Mersana Therapeutics is a Buy
- The Bollinger Bands (100) for Mersana Therapeutics is (1.59 - 2.31), which suggest Mersana Therapeutics is a Buy
* Mersana Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.